Literature DB >> 10993449

Surgical treatment of tympanosclerosis.

S Albu1, G Babighian, F Trabalzini.   

Abstract

OBJECTIVE: To report the hearing results of the surgical treatment of tympanosclerosis. STUDY
DESIGN: A retrospective review of surgically treated cases of tympanosclerosis.
SETTING: A tertiary referral center. PATIENTS: One hundred fifteen patients with middle ear tympanosclerosis operated on between 1987 and 1996, with an average age of 36 years (range 18-59 years). Cases were classified into four groups according to Wielinga and Kerr. Those with an associated cholesteatoma were excluded. INTERVENTION: Depending on the ossicular status, either mobilization of the major ossicles or epitympanic bypass procedure, mobilization of the stapes or stapedectomy. MAIN OUTCOME MEASURES: The postoperative pure-tone average was compared with the preoperative levels by use of conventional audiometry. The air-bone gap was measured.
RESULTS: The average postoperative air-bone gap was 18.0+/-10.21 dB in the type II group (attic fixation of the malleus-incus complex with a mobile stapes). 21.8+/-9.5 dB in the type III group (mobile malleus-incus complex, if present, with stapes footplate fixation), and 22.92+/-10.03 dB in the type IV group (fixation of both the stapes footplate and the malleus-incus complex). Patients with a fixed malleus and mobile stapes had significantly better hearing results than those with stapes fixation (p = 0.042, Mann-Whitney U test).
CONCLUSION: In ossicular attic fixation, atticotomy and mobilization of ossicles yielded better results than did the epitympanic bypass procedure. The difference, however, did not reach statistical significance. Patients with fixed stapes treated with stapedectomy displayed good hearing results immediately after surgery, but the air-bone gap deteriorated after some time.

Entities:  

Mesh:

Year:  2000        PMID: 10993449

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  10 in total

1.  Myringosclerosis: an indication of a blocked aditus.

Authors:  M K Manjunath; R Jyothi Swarup; Geetha Chary; M D Shadab
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-11-04

2.  Hearing results of surgery for tympanosclerosis.

Authors:  Milan D Stankovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-14       Impact factor: 2.503

3.  Ossiculoplasty with a cartilage-connecting hydroxyapatite prosthesis for tympanosclerotic stapes fixation.

Authors:  Hirokazu Kawano; Keiji Matsuda; Haruka Nakanishi; Katsuhiro Toyama; Noriaki Nagai; Tetsuya Tono
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-10       Impact factor: 2.503

4.  The effect of stapes fixation on hearing results in tympanosclerosis treated by mobilization.

Authors:  Erdal Sakalli; Cengiz Celikyurt; Burak Guler; Sultan Biskin; Hasan Deniz Tansuker; Selcuk Cem Erdurak
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-04       Impact factor: 2.503

5.  Audiological results after total ossicular reconstruction for stapes fixation.

Authors:  M Soledad Boleas-Aguirre; Iñigo Ruiz de Erenchun-Lasa; M Dolores Bulnes-Plano
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-01       Impact factor: 2.503

6.  Tympanosclerosis and our surgical results.

Authors:  Hale Aslan; Hüseyin Katilmiş; Sedat Oztürkcan; Ali Ekber Ilknur; Sinan Başoğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-09-22       Impact factor: 2.503

Review 7.  [Treatment of tympanosclerosis].

Authors:  A Gurr; H Hildmann; T Stark; S Dazert
Journal:  HNO       Date:  2008-06       Impact factor: 1.284

8.  Tympanosclerosis revisited.

Authors:  Kamaljit Kaur; Nishi Sonkhya; A S Bapna
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-04

9.  Labyrinthine fenestration for stapes fixation in chronic ear disease others than otosclerosis.

Authors:  Yannick Zaugg; Thomas Linder
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-05       Impact factor: 2.503

10.  Endoscopic transcanal management of tympanosclerosis.

Authors:  Ali Özdek
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-20       Impact factor: 2.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.